BioReference provides employers with flexible program options for employee screening ELMWOOD PARK, N.J., May 13, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today launched the BioReference Employer Solution, a COVID-19 screening program that assists employers’ decisions about return-to-work policies. Test results play a critical role in the fight against COVID-19 by identifying […]
Category Archives: Press Release
Press Release
OPKO Health’s BioReference Laboratories and Westchester Medical Center Health Network Enter Into Strategic Laboratory Collaboration to Deliver Operational and Diagnostic Services
13
May
May
ELMWOOD PARK, N.J., May 13, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced a strategic collaboration with the Westchester Medical Center Health Network (WMCHealth), a 1,700-bed healthcare system headquartered in Valhalla, New York, to provide full laboratory administrative services, laboratory operations, reference testing and outpatient laboratory services. WMCHealth has 10 hospitals […]
Press Release
OPKO Health’s BioReference Laboratories Launches COVID-19 Antibody Screening for New York City Residents
08
May
May
In partnership with NYC Health + Hospitals, BioReference is expanding access to COVID-19 antibody testing ELMWOOD PARK, N.J., May 8, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the launch of COVID-19 antibody screening available to New York City residents in partnership with New York City Health and Hospital Corporation (NYC Health […]
Press Release
OPKO Health’s BioReference Laboratories in Partnership with New York State Initiates Testing for COVID-19 Antibodies
29
Apr
Apr
BioReference will broaden availability of serological antibody tests to states, hospitals and healthcare organizations throughout the United States ELMWOOD PARK, N.J., April 29, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), announced that beginning today it will offer antibody blood tests to detect an immune response after infection with the COVID-19 virus. Antibody testing […]
Press Release
OPKO Health’s BioReference Laboratories Partners with Hospitals Nationwide to Provide Prioritized Testing to Inpatients with Suspected Coronavirus Disease 2019 (COVID-19)
06
Apr
Apr
ELMWOOD PARK, N.J., April 6, 2020 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced that it will continue to prioritize COVID-19 testing for hospital inpatients and critically ill patients around the country. “Our goal is to maintain the current 24 hour turnaround time for these patients,” said Jon R. Cohen, M.D., Executive Chairman of […]
Press Release
OPKO Health’s BioReference Laboratories and City of Miami Provide Testing for Coronavirus Disease 2019 (COVID-19)
24
Mar
Mar
BioReference will offer COVID-19 testing for public drive-through facilities for Miami residents and Larkin Community Hospital ELMWOOD PARK, N.J., March 24, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a collaboration with the City of Miami to provide coronavirus disease 2019 (COVID-19) testing. BioReference will provide COVID-19 testing at drive-through locations […]
Press Release
OPKO Health’s BioReference Laboratories and City of Detroit Provide Testing for Coronavirus Disease 2019 (COVID-19)
23
Mar
Mar
BioReference will offer COVID-19 testing for public drive-through facilities for Detroit residents ELMWOOD PARK, N.J., March 23, 2020 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a collaboration with the City of Detroit to provide coronavirus disease 2019 (COVID-19) testing. BioReference will provide COVID-19 testing at drive-through locations for Detroit residents by appointment. “The impact that expanded testing will […]
Press Release
OPKO Health’s BioReference Laboratories and State of New Jersey Provide Testing for Coronavirus Disease 2019 (COVID-19)
20
Mar
Mar
BioReference offers COVID-19 testing for first five NJ drive-through testing facilities in the counties of Burlington, Essex, Hudson, Ocean and Union BioReference to participate in NJ press conference on Friday, March 20 at 2:00 p.m. ET ELMWOOD PARK, N.J., March 20, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a collaboration […]
Press Release
OPKO Health’s BioReference Laboratories and NYC Health + Hospitals Enter into Laboratory Collaboration to Provide Testing for Coronavirus Disease 2019 (COVID-19)
17
Mar
Mar
OPKO Health’s BioReference Laboratories and NYC Health + Hospitals Enter into Laboratory Collaboration to Provide Testing for Coronavirus Disease 2019 (COVID-19) BioReference Laboratories commits to testing 5,000 New Yorkers each day ELMWOOD PARK, N.J., March 17, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a collaboration with the New York City […]
Press Release
OPKO Health’s BioReference Laboratories Offers Testing for Coronavirus Disease 2019 (COVID-19)
13
Mar
Mar
In partnership with NY State Department of Health, BioReference will provide COVID-19 testing for the first public drive-through testing facility on the East Coast COVID-19 tests now available for use by healthcare providers throughout the US ELMWOOD PARK, N.J., March 13, 2020 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), is now […]
